Neuralink, Elon Musk’s brain-computer interface (BCI) company, has received the FDA's “breakthrough device” designation for its innovative 'Blindsight' implant.
Synchron, a competitor to Neuralink, has announced one of its patients with ALS is now able to control devices using only his mind with its brain chip implant.
Neuralink has implanted its experimental N1 brain-computer interface (BCI) within a second patient, with Elon Musk, the company's CEO, saying the procedure is “working very well.”
Neuralink recently revealed that it chose to postpone the insertion of a second brain chip implant in a procedure that had been eagerly anticipated by the medical and tech communities.
The FDA has approved Elon Musk's Neuralink to implant its experimental brain chip technology in a second individual, following issues that arose with its first patient.